Focus on Improving Oncology Care Worldwide to Boost Adoption of Oncology Therapies
Cancer is deemed as one of the most glaring causes of mortality and morbidity across the world. Due to advancements in technology and a significant amount of research, the oncology nutrition market is expected to witness considerable growth in the coming years. Oncology nutrition continues to remain an imperative area of focus for healthcare providers due to a consistent rise in the number of cases of malnutrition induced by tumors worldwide. Oncology nutrition plays an important role in improving bodily resources, tolerance of cancer treatments, and the overall quality of life. The decline in tolerance to cancer therapy is expected to provide fertile grounds of growth for companies operating in the current oncology nutrition market.
Get the sample copy of report@ https://qyresearchmedical.com/sample/111663
The significant rise in nutritional wasting and nutritional risk among cancer patients is a major factor that is anticipated to boost the growth of the oncology nutrition market during the forecast period. Participants in the current market landscape are currently investigating the potential benefits of adopting a multidisciplinary approach wherein targeted nutrition is likely to be imperative to enhance the quality of oncology care. Evolving guidelines, surge in observational studies, and growth in the number of clinical trials worldwide are some of the leading factors that are expected to propel the growth of the market for oncology nutrition in the coming years. At the back of these factors, the global oncology nutrition market is expected to reach ~US$ 1.4 Bn by the end of 2027.
Progress in Nutritional Screening and Assessment Techniques to Drive Market
Nutritional screening and assessment techniques are integral to detect the identification of patients that are at a greater risk of malnourishment. Several studies have revealed that the incorporation of malnutrition screening in oncology care is expected to improve nutritional assessment and prevent malnutrition among patients. While nutritional risk continues to come under the radar, oncology nutrition is projected to gain a fair amount of momentum over the course of the assessment period. The demand for oncology nutrition is expected to further grow due to the notable surge in the adoption of nutritional assessment programs particularly during cancer cachexia and precachexia. Data collection techniques pertaining to the nutritional status of various patients have progressed at a rapid pace over the past decade. Due to these advancements, tailored oncology nutrition therapies have emerged as an ideal solution for cancer patients who are susceptible to malnutrition.
Get a glimpse of the in-depth analysis through our Report Brochure
Oncology nutrition therapies vary from patients to patients and at present, individualized oncology nutritional counseling has gained considerable pace. Oncology nutrition is increasingly being used to prevent nutritional deterioration among patients who are undergoing cancer care. Oral oncology nutrition is likely to gain considerable popularity as it has emerged as the preferred route of feeding. The demand for oncology nutrition to enhance the quality of life in cancer patients is on the rise– a major factor that is expected to provide a significant boost to the growth of the oncology nutrition market during the assessment period.
Stringent Guidelines Governing Oncology Nutrition to Influence Market Growth
One of the most glaring challenges that participants in the oncology nutrition market have had to deal with over several decades is the inadequate and unclear guidelines laid down by authoritative bodies due to which, oncology nutrition remained at the backseat. However, with additional research and growing awareness regarding the benefits of oncology nutrition, the structure within the healthcare systems is evolving. At present, within the oncology nutrition market, clinical nutrition specialists and oncologists are increasingly collaborating with each other in their efforts to improve oncology nutrition and oncology care. At present, recently laid down guidelines from different scientific bodies have focused on some key areas that are expected to improve the adoption of oncology nutrition in the coming years, including regular oncology nutritional therapy particularly for malnourished cancer patients, home artificial nutrition prescription, nutritional management, etc. The new guidelines would offer a boost to the adoption of oncology nutrition in the coming years, as the uptake of improved oncology nutrition therapies for cancer patients undergoing chemoradiotherapy is on the rise.
View full report@ https://qyresearchmedical.com/report/oncology-nutrition-market-distribution-channel-inpatient-nutrition-and-outpatient-nutrition-nutrition-enteral-nutrition-and-parenteral-nutrition-formula-standard-formula-elemental-formula-and-specialized-for-019-2030/111663
The global oncology nutrition market is expected to grow at a healthy CAGR of ~6% during the forecast period. The market growth can be primarily attributed to a range of factors, including rising in the prevalence of cancer patients, technological advancements, research & development activities, and growing awareness regarding oncology nutrition are some of the leading factors that will provide an impetus to the growth of the market for oncology nutrition during the forecast period. Focus on improving nutritional assessment among cancer patients due to the rise in the number of malnutrition cases will also play an important role in boosting the growth of the oncology nutrition market.
Oncology Nutrition Market: Overview
The oncology nutrition market for the historical period 2017–2018 and forecast period 2019–2027, growing incidence of cancer, cancer supportive care products to meet the growing demand to treat cancer, entry of new players, and increase in access to health care are anticipated to drive the global oncology nutrition market
According to the report, the global oncology nutrition market was valued at US$ 836 Mn in 2018 and is projected to expand at a CAGR of ~6% from 2019 to 2027
Rise in Incidence of Cancer and Surge in Awareness about Usage and Benefits of Oncology Nutrition Supplements: A Key Driver
Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Approximately 70% of deaths from cancer occur in low- and middle-income countries.
Late-stage presentation and inaccessible diagnosis and treatment are common in low- and middle-income countries. In 2017, only 26% of low-income countries reported having pathology services generally available in the public sector.
Each cancer type requires unique treatment. Hence, increase in prevalence of cancer and the need for personalized medicine and nutrition are expected to increase the uptake of oncology nutrition diet. This is likely to provide significant opportunities for players in this market.
Focus on Geographic Expansion
Companies in the global oncology nutrition market are increasingly turning to in-licensing and collaboration agreements to launch new products in North America and Europe. Rise in demand to develop advanced or standard nutritional products for cancer, economic growth, and increase in awareness about oncology nutrition diet present significant opportunities for players operating in the global oncology nutrition market.
According to industry experts, high cost of oncology nutrition could hamper the market growth. This is particularly true for various underdeveloped and developing countries. Incidence of cancer is high in developing regions such as Asia, Africa, Latin America, and the Middle East. Hence, growth of oncology nutrition is expected to be faster in these regions. However, high cost of oncology specific supplements would be a deterrent for exploiting the full potential of these regions.
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111663/2900
Stringent Regulatory Requirements to Hamper Market
Stringent regulatory requirements and long procedure for FDA approval have discouraged oncology nutrition manufacturers in the U.S. These are looking at regions such as Europe and Asia to launch newer products. Small private companies are doing much work in this area with some big pharmaceutical companies. These have put parenteral oncology nutrition for clinical trials.
Oncology Nutrition Market: Competition Landscape
This report profiles major players in the global oncology nutrition market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The oncology nutrition market is less fragmented, with the presence of a more international as well as regional players
Leading players operating in the global oncology nutrition market are
- Danone S.A.
- Pfizer Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Grifols S.A.
- Baxter International, Inc.
- Nestlé S.A.
- Abbott Laboratories
- Sichuan Kelun Pharmaceutical Co.,
- which account for more than 70% share of the market
Key Questions Answered in Oncology Nutrition Market Report
- What is the scope of growth of parenteral nutrition in the oncology nutrition market?
- What will be the Y-o-Y growth of the oncology nutrition market between 2019 and 2027?
- What is the influence of changing trends in oncology diseases on the global oncology nutrition market?
- Will North America continue to remain the most profitable regional market for oncology nutrition providers?
- Which factors are anticipated to impede the growth of the global oncology nutrition market during the forecast period?
- Which are the leading companies in the global oncology nutrition market?
Oncology Nutrition Market – Segmentation
- Inpatient Nutrition
- Outpatient Nutrition
- Enteral Nutrition
- Parenteral Nutrition
- Standard Formula
- Elemental Formula
- Specialized Formula
- Head and Neck Cancers
- Colorectal Cancer
- Hematology Cancer
- Prostate Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Lun Cancer
- Pancreatic Cancer
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
TABLE OF CONTENT
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Oncology Nutrition Market
4. Market Overview
4.1.1. Formula Definition
4.1.2. Industry Evolution / Developments
4.3. Market Dynamics
4.4. Global Oncology Nutrition Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Health Care Industry Overview
5.2. Cancer Incidence, by Key Country, in 2017
6. Global Oncology Nutrition Market Analysis and Forecast, by Nutrition
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Oncology Nutrition Market Value Forecast, by Nutrition, 2017–2027
6.2.1. Enteral Nutrition
6.2.2. Parenteral Nutrition
6.3. Global Oncology Nutrition Market Attractiveness, by Nutrition
7. Global Oncology Nutrition Market Analysis and Forecast, by Formula
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Oncology Nutrition Market Value Forecast, by Formula, 2017–2027
7.2.1. Standard Formula
7.2.2. Elemental Formula
7.2.3. Specialized Formula
7.3. Global Oncology Nutrition Market Attractiveness, by Formula
8. Global Oncology Nutrition Market Analysis and Forecast, by Cancer
8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global Oncology Nutrition Market Value Forecast, by Cancer, 2017–2027
8.2.1. Head and Neck Cancers
8.2.2. Colorectal Cancer
8.2.3. Hematology Cancer
8.2.4. Prostate Cancer
8.2.5. Breast Cancer
8.2.6. Gastrointestinal Cancer
8.2.7. Lung Cancer
8.2.8. Pancreatic Cancer
8.2.9. Other Cancers
8.3. Global Oncology Nutrition Market Attractiveness, by Cancer
9. Global Oncology Nutrition Market Analysis and Forecast, by Distribution Channel
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111663/2900
You can place an order or ask any questions, please feel free to contact firstname.lastname@example.org | +1 9197 992 333
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us: